Stone House Investment Management »

Vertex Pharmaceuticals Incorporated shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $52k 124 418.01
2023-12-31 $51k 124 406.89
2023-09-30 $43k 124 347.74
2023-06-30 $44k 124 351.91
2023-03-31 $39k 124 315.07

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Total Usd (IUSB)
Procter & Gamble Company (PG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Mbs Etf (MBB)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Msci Emrg Chn (EMXC)

View all positions for Stone House Investment Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated